Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression-Reference-Cited by-同舟云学术

Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression

Published:2017-10-12 Issue:3 Volume:59 Page:529-535
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Donnelly David J.,Smith R. Adam,Morin Paul,Lipovšek Daša,Gokemeijer Jochem,Cohen Daniel,Lafont Virginie,Tran Tritin,Cole Erin L.,Wright Martin,Kim Joonyoung,Pena Adrienne,Kukral Daniel,Dischino Douglas D.,Chow Patrick,Gan Jinping,Adelakun Olufemi,Wang Xi-Tao,Cao Kai,Leung David,Bonacorsi Samuel J.,Hayes Wendy

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference32 articles.

1. The blockade of immune checkpoints in cancer immunotherapy

2. Role of the PD-1 Pathway in the Immune Response

3. PD-1 and Its Ligands in Tolerance and Immunity

4. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

5. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer;Clinical and Experimental Medicine;2024-07-18

2. Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer;Journal for ImmunoTherapy of Cancer;2024-07

3. PD-L1 has a heterogeneous and dynamic expression in gastric cancer with implications for immunoPET;Frontiers in Immunology;2024-06-10

4. Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities;Frontiers in Medicine;2024-06-07

5. Improving the pharmacokinetics, biodistribution and plasma stability of monobodies;Frontiers in Pharmacology;2024-04-04